Also trades as: RAONF (OTC) · $vol 0M
RAC.AX ASX
Race Oncology Limited
1W: -6.3%
1M: -10.3%
3M: -12.7%
YTD: -21.6%
1Y: +57.4%
3Y: +93.0%
5Y: -40.9%
A$1.92 ($1.34)
+0.06 (+3.23%)
Weekly Expected Move ±5.3%
A$2
A$2
A$2
A$2
A$2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$281K
-105.2% ▼
Operating Income
-$12M
-229.6% ▼
Net Income
-$11M
-131.6% ▼
EPS (Diluted)
$-0.06
-122.7% ▼
EBITDA
-$12M
-174.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $708K | $3M | $4M | $6M | $0 |
| YoY Growth | +82.7% | +342.8% | +27.7% | +51.0% | -100.0% |
| Cost of Revenue | $281K | $281K | $281K | $635K | $281K |
| Gross Profit | $427K | -$281K | $2M | $5M | -$281K |
| Gross Margin | 60.3% | -9.0% | 55.5% | 89.5% | — |
| R&D Expenses | $6M | $8M | $11M | $6M | $8M |
| SG&A Expenses | $5M | $5M | $7M | $3M | $5M |
| Operating Expenses | $11M | $13M | $18M | $9M | $12M |
| Operating Income | -$11M | -$13M | -$18M | -$4M | -$12M |
| Operating Margin | -1622.8% | -414.4% | -445.5% | -62.4% | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$12M | -$13M | -$18M | -$5M | -$14M |
| Tax Expense | -$708K | -$3M | -$4M | -$5M | -$3M |
| Net Income | -$11M | -$10M | -$14M | -$5M | -$11M |
| Net Margin | -1582.6% | -316.6% | -345.2% | -79.2% | — |
| EPS (Diluted) | $-0.07 | $-0.06 | $-0.08 | $-0.03 | $-0.06 |
| EBITDA | -$12M | -$13M | -$14M | -$4M | -$12M |
| Shares Outstanding | 153M | 161M | 165M | 172M | 179M |